General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Medtronic(MODEST), Amgen(MODEST), Novartis(SIGNIFICANT), Edwards LifeSciences(SIGNIFICANT), Abbott Laboratories(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Urovant(MODEST), Cytokinetics(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Merck & Co., Inc.(SIGNIFICANT), Eli Lilly and Company(MODEST), Johnson & Johnson(SIGNIFICANT), Pfizer(MODEST) RESEARCH/RESEARCH GRANTS: NHLBI(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Boston Scientific(MODEST)

View Full Disclosure